ArticleInternational journal of molecular sciences2023

Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells.

Robert Kleszcz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.